NASDAQ: XERS
Xeris Biopharma Holdings Inc Stock Ownership - Who owns Xeris Biopharma Holdings?

Insider buying vs selling

Have Xeris Biopharma Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marla PerskyDirector2025-09-1115,500$7.72
$119.61kSell
Jeffrey W. ShermanDirector2025-08-2842,232$7.92
$334.52kSell
Jeffrey W. ShermanDirector2025-08-2847,040$6.66
$313.29kBuy
John JohnsonDirector2025-08-13107,500$7.32
$786.47kSell
Dawn HalkuffDirector2025-08-1242,500$7.28
$309.23kSell
John Patrick Shannon Jr.Chief Executive Officer and Director2025-08-0136,918$5.38
$198.62kSell
Kevin McCullochPresident and Chief Operating Officer2025-08-0114,651$5.38
$78.82kSell
Kevin McCullochPresident and Chief Operating Officer2025-06-1325,000$4.38
$109.47kBuy
Kevin McCullochPresident and Chief Operating Officer2025-04-02733$5.15
$3.77kSell
Beth HechtChief Legal Officer and Corporate Secretary2025-03-2040,000$5.43
$217.24kSell

1 of 3

XERS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XERS insiders and whales buy or sell their stock.

XERS Shareholders

What type of owners hold Xeris Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.14%11,536,321$86.41MInstitution
Vanguard Group Inc6.08%9,816,937$73.53MInstitution
Redmile Group LLC3.35%5,413,284$40.55MInsider
Paul R. Edick2.40%3,868,354$28.97MInsider
D E Shaw Co Inc2.38%3,835,407$28.73MInstitution
State Street Corp2.34%3,783,200$28.34MInstitution
Geode Capital Management LLC2.26%3,650,688$27.34MInstitution
Morgan Stanley2.26%3,642,584$27.28MInstitution
Qube Research Technologies Ltd1.91%3,089,771$23.14MInstitution
Millennium Management LLC1.82%2,933,620$21.97MInstitution

1 of 3

XERS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XERS56.08%15.19%Net SellingNet Selling
GPCR31.63%12.59%Net SellingNet Selling
CVAC5.19%0.00%
INVA59.68%40.32%Net SellingNet Selling
TRML58.17%41.83%Net BuyingNet Buying

Xeris Biopharma Holdings Stock Ownership FAQ

Who owns Xeris Biopharma Holdings?

Xeris Biopharma Holdings (NASDAQ: XERS) is owned by 56.08% institutional shareholders, 15.19% Xeris Biopharma Holdings insiders, and 28.72% retail investors. Redmile Group LLC is the largest individual Xeris Biopharma Holdings shareholder, owning 5.41M shares representing 3.35% of the company. Redmile Group LLC's Xeris Biopharma Holdings shares are currently valued at $40.55M.

If you're new to stock investing, here's how to buy Xeris Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.